ARQT vs CLOV
Arcutis Biotherapeutics Inc (ARQT) versus Clover Health Investments Corp (CLOV) — a side-by-side from cached financials, not a winner call.
Arcutis Biotherapeutics Inc (ARQT) is a biotechnology company listed on US.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Latest reported ARQT revenue for 2024-12-31 was $196.5M. Net income was -$140.0M. Revenue was up 229.7% from 2023-12-31 to 2024-12-31. ARQT currently screens at market cap $1.64B.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
ARQT currently screens at market cap $1.64B. CLOV currently screens at market cap $1.55B.
Not investment advice. Open the ARQT and CLOV stock pages for the full models.
Not investment advice.